Cite
HARVARD Citation
Oliva, E. et al. (n.d.). Early lenalidomide treatment for low and intermediate‐1 International Prognostic Scoring System risk myelodysplastic syndromes with del(5q) before transfusion dependence. Cancer medicine. pp. 1789-1797. [Online].